Activity and feasibility of biweekly carboplatin (Cb) plus Gemcitabine (G) as first line treatment in small cell lung cancer (SCLC) with extensive disease (ED): P1-222
Journal of Thoracic Oncology（2007）
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要